Completed PHASE2 INTERVENTIONAL 4-arm NCT03727321

FMT and Fiber in Patients With Metabolic Syndrome (FMT)

Fecal Microbial Transplantation and Fiber Supplementation in Subjects With Obesity and Metabolic Syndrome

Sponsor: The Weston A. Price Foundation

Interventions Cellulose Fecal Microbial Transplant Fiber

Updated 6 times since 2018 Last updated: May 1, 2020 Started: Jul 1, 2018 Primary completion: Jan 16, 2020 Completion: Jan 16, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Metabolic Syndrome and Obesity, this trial is completed. The trial is conducted by The Weston A. Price Foundation and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jun 2019 — Jun 2020 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Dec 2018 — Jun 2019 [monthly]

Recruiting PHASE2

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Weston A. Price Foundation
University of Alberta

Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edmonton, Canada